Биологические науки и медицина
Chimeric Antigen Receptors
70%
Neoplasms
66%
Plasma Gases
51%
Apoptosis Regulatory Proteins
41%
Natural Killer Cells
40%
Cell Line
38%
Transgenes
35%
Immunogenic Cell Death
34%
Breast Neoplasms
33%
HMGB1 Protein
26%
NF-kappa B
24%
In Vitro Techniques
24%
Cancer-Associated Fibroblasts
24%
Cytokines
24%
Recombinant Proteins
22%
Apoptosis
21%
Benzo(a)pyrene
21%
Gene Knockout Techniques
21%
Vaccinia virus
20%
Adenocarcinoma of Lung
20%
Drug Therapy
19%
Up-Regulation
19%
Automobiles
19%
Proteins
19%
Nucleic Acids
17%
Autophagy
16%
Antineoplastic Agents
16%
Breast
16%
Adenocarcinoma
16%
Inhibitor of Apoptosis Proteins
16%
Therapeutics
15%
Macrophage Inflammatory Proteins
15%
Hypoxia
15%
Human Milk
14%
Chloroquine
14%
MicroRNAs
14%
MCF-7 Cells
14%
Intravenous Injections
14%
human lactaptin
13%
Innate Immunity
13%
Chemotactic Factors
13%
Interleukin-5
12%
Pharmaceutical Preparations
12%
G(A1) ganglioside
11%
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
11%
Immunoassay
11%
Intraperitoneal Injections
11%
Keratinocytes
11%
enhanced green fluorescent protein
10%
Enzyme-Linked Immunosorbent Assay
10%
Физика и астрономия
plasma jets
100%
cancer
88%
viability
37%
tumors
36%
cultured cells
30%
mice
29%
animal models
24%
cells
23%
helium plasma
22%
serums
20%
spheroids
20%
argon plasma
20%
therapy
18%
breast
18%
interactions
16%
electric potential
14%
boxes
14%
irradiation
13%
proteins
13%
electrodes
10%
propagation
10%
sensitivity
10%
kidneys
9%
fluids
8%
stem cells
7%
death
7%
simulation
6%
gas flow
6%
atmospheric pressure
6%
safety
6%
burn-in
6%
plasma generators
5%
temperature control
5%
Биология и сельское хозяйство
neoplasms
40%
Heterocephalus glaber
27%
neoplasm progression
26%
fibroblasts
22%
natural killer cells
21%
cytotoxicity
18%
gene targeting
18%
neoplasm cells
18%
cells
14%
antigens
13%
mice
12%
receptors
11%
prostatic neoplasms
9%
DNA
8%
therapeutics
6%
glioblastoma
6%
apoptosis
6%
kappa-casein
5%
Mus musculus
5%
human cell lines
5%
cell lines
5%
cyclophosphamide
5%
adenocarcinoma
5%
antineoplastic agents
5%